These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523 [TBL] [Abstract][Full Text] [Related]
17. [Hepatic and hematological toxicities of therapy with H2-receptor antagonists]. Hirota M; Matsushita M; Kiyota K; Shiroeda O; Inokuchi H; Onishi R; Kawai K Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2132-6. PubMed ID: 8105121 [No Abstract] [Full Text] [Related]
18. I saw part of a news report linking heartburn medication to pneumonia. Please explain. Mayo Clin Health Lett; 2005 Mar; 23(3):8. PubMed ID: 15816066 [No Abstract] [Full Text] [Related]
19. Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance. Castillo JR; Torelló J; Hernandez A Eur J Clin Pharmacol; 2000 May; 56(2):187-9. PubMed ID: 10877015 [No Abstract] [Full Text] [Related]
20. Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine. Pineda JA; Larrauri J; Macías J; Hernández A; Guijarro J; Sayago M; Gavilán F; Aguilar J; Lissen E J Hepatol; 1999 Oct; 31(4):777-8. PubMed ID: 10551406 [No Abstract] [Full Text] [Related] [Next] [New Search]